These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31653008)

  • 1. Galeterone and The Next Generation Galeterone Analogs, VNPP414 and VNPP433-3β Exert Potent Therapeutic Effects in Castration-/Drug-Resistant Prostate Cancer Preclinical Models In Vitro and In Vivo.
    Kwegyir-Afful AK; Ramalingam S; Ramamurthy VP; Purushottamachar P; Murigi FN; Vasaitis TS; Huang W; Kane MA; Zhang Y; Ambulos N; Tiwari S; Srivastava P; Nnane IP; Hussain A; Qiu Y; Weber DJ; Njar VCO
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31653008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salinization Dramatically Enhance the Anti-Prostate Cancer Efficacies of AR/AR-V7 and Mnk1/2 Molecular Glue Degraders, Galeterone and VNPP433-3β Which Outperform Docetaxel and Enzalutamide in CRPC CWR22Rv1 Xenograft Mouse Model.
    Thankan RS; Thomas E; Purushottamachar P; Weber DJ; Njar VCO
    Bioorg Chem; 2023 Oct; 139():106700. PubMed ID: 37392559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models.
    Thomas E; Thankan RS; Purushottamachar P; Huang W; Kane MA; Zhang Y; Ambulos NP; Weber DJ; Njar VCO
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome profiling reveals that VNPP433-3β, the lead next-generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial-mesenchymal transition and stem cell markers.
    Thomas E; Thankan RS; Purushottamachar P; Huang W; Kane MA; Zhang Y; Ambulos N; Weber DJ; Njar VCO
    Mol Carcinog; 2022 Jul; 61(7):643-654. PubMed ID: 35512605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo.
    Kwegyir-Afful AK; Ramalingam S; Purushottamachar P; Ramamurthy VP; Njar VC
    Oncotarget; 2015 Sep; 6(29):27440-60. PubMed ID: 26196320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in mice.
    Kwegyir-Afful AK; Murigi FN; Purushottamachar P; Ramamurthy VP; Martin MS; Njar VCO
    Oncotarget; 2017 Aug; 8(32):52381-52402. PubMed ID: 28881737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galeterone and VNPT55 disrupt Mnk-eIF4E to inhibit prostate cancer cell migration and invasion.
    Kwegyir-Afful AK; Bruno RD; Purushottamachar P; Murigi FN; Njar VC
    FEBS J; 2016 Nov; 283(21):3898-3918. PubMed ID: 27618366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale synthesis of galeterone and lead next generation galeterone analog VNPP433-3β.
    Purushottamachar P; Thomas E; Thankan RS; Rudchenko V; Huang G; Njar VCO
    Steroids; 2022 Sep; 185():109062. PubMed ID: 35690119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The retinamide VNLG-152 inhibits f-AR/AR-V7 and MNK-eIF4E signaling pathways to suppress EMT and castration-resistant prostate cancer xenograft growth.
    Ramamurthy VP; Ramalingam S; Gediya LK; Njar VCO
    FEBS J; 2018 Mar; 285(6):1051-1063. PubMed ID: 29323792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.
    Thamilselvan V; Menon M; Thamilselvan S
    Int J Cancer; 2016 Oct; 139(7):1632-47. PubMed ID: 27198552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Degradation of Androgen Receptor by VNPP433-3β in Castration-Resistant Prostate Cancer Cells Implicates Interaction with E3 Ligase MDM2 Resulting in Ubiquitin-Proteasomal Degradation.
    Thomas E; Thankan RS; Purushottamachar P; Weber DJ; Njar VCO
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel galeterone analogs act independently of AR and AR-V7 for the activation of the unfolded protein response and induction of apoptosis in the CWR22Rv1 prostate cancer cell model.
    McCarty DJ; Huang W; Kane MA; Purushottamachar P; Gediya LK; Njar VCO
    Oncotarget; 2017 Oct; 8(51):88501-88516. PubMed ID: 29179452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and β-catenin.
    Xu Y; Liao S; Wang L; Wang Y; Wei W; Su K; Tu Y; Zhu S
    Cancer Chemother Pharmacol; 2021 Jan; 87(1):85-93. PubMed ID: 33159561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel C-4 heteroaryl 13-cis-retinamide Mnk/AR degrading agents inhibit cell proliferation and migration and induce apoptosis in human breast and prostate cancer cells and suppress growth of MDA-MB-231 human breast and CWR22Rv1 human prostate tumor xenografts in mice.
    Mbatia HW; Ramalingam S; Ramamurthy VP; Martin MS; Kwegyir-Afful AK; Njar VC
    J Med Chem; 2015 Feb; 58(4):1900-14. PubMed ID: 25634130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
    McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
    Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Novel Steroidal Androgen Receptor Degrading Agents Inspired by Galeterone 3β-Imidazole Carbamate.
    Purushottamachar P; Kwegyir-Afful AK; Martin MS; Ramamurthy VP; Ramalingam S; Njar VC
    ACS Med Chem Lett; 2016 Jul; 7(7):708-13. PubMed ID: 27437082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
    Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T
    Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells.
    Khurana N; Chandra PK; Kim H; Abdel-Mageed AB; Mondal D; Sikka SC
    Antioxidants (Basel); 2020 Jan; 9(1):. PubMed ID: 31940946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor (AR) degradation enhancer ASC-J9
    Cheng MA; Chou FJ; Wang K; Yang R; Ding J; Zhang Q; Li G; Yeh S; Xu D; Chang C
    Cancer Lett; 2018 Mar; 417():182-191. PubMed ID: 29203251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor Effect of Hedgehog Signaling Inhibitor, Vismodegib, on Castration-resistant Prostate Cancer.
    Ishii A; Shigemura K; Kitagawa K; Sung SY; Chen KC; Yi-Te C; Liu MC; Fujisawa M
    Anticancer Res; 2020 Sep; 40(9):5107-5114. PubMed ID: 32878799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.